 BOCA RATON, Fla.--BUSINESS WIRE--TherapeuticsMD, Inc. NASDAQ: TXMD, an innovative, leading womens healthcare company, today announced the appointment of Hugh ODowd as President. Mr. ODowd succeeds John C.K. Milligan, IV, who the Company recently appointed as Chief Executive Officer of its vitaCare Prescription Services business. I am delighted to welcome Hugh as President of TherapeuticsMD. Hugh has a significant operating and strategic history with both large and small pharmaceutical c 